|
Volumn 21, Issue 1, 2001, Pages 21-26
|
Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: Clinical and economic implications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HALOPERIDOL;
VALPROATE SEMISODIUM;
ARTICLE;
CLINICAL ARTICLE;
COGNITION;
CONTROLLED STUDY;
HALLUCINATION;
HEALTH CARE COST;
HOSPITALIZATION;
HUMAN;
LENGTH OF STAY;
PARANOIA;
PRIORITY JOURNAL;
PSYCHOSOCIAL WITHDRAWAL;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ADULT;
ANTIMANIC AGENTS;
ANTIPSYCHOTIC AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HALOPERIDOL;
HOSPITALIZATION;
HUMANS;
MALE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
VALPROIC ACID;
|
EID: 0035142371
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200102000-00006 Document Type: Article |
Times cited : (37)
|
References (15)
|